Crossmark

In vitro activity of ceftobiprole and dalbavancin against a collection of coagulase-negative staphylococci isolates from clinical samples with reduced susceptibility to daptomycin and/or resistant to linezolid or glycopeptides

Crossref DOI link: https://doi.org/10.1016/j.eimc.2022.06.011

Published Print: 2023-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Velasco de la Fuente, Silvia

Fernández-Martinez, Marta

Rodríguez Lozano, Jesús

Pablo-Marcos, Daniel

Siller, María

Calvo Montes, Jorge
License Information

Text and Data Mining valid from 2023-11-01
More Information

This article is maintained by: Elsevier

Article Title: In vitro activity of ceftobiprole and dalbavancin against a collection of coagulase-negative staphylococci isolates from clinical samples with reduced susceptibility to daptomycin and/or resistant to linezolid or glycopeptides

Journal Title: Enfermedades Infecciosas y Microbiología Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.eimc.2022.06.011

Content Type: article

Copyright: © 2022 Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below